Northwestern investigators are exploring the potential of bacterial toxins to be turned into therapeutic agents to effectively ward off disease.
Northwestern Medicine scientists have identified a novel strategy that could improve the efficacy of immunotherapy in treating chronic viral infections.
Armed with a prestigious new grant, investigators prepare to rapidly translate scientific breakthroughs into better brain tumor therapies. Read the story in Northwestern Medicine magazine.
A new study has identified genes that, when inhibited, may slow or stop the progression of primary effusion lymphoma.
A team of scientists developed a novel stem cell model to demonstrate that a pathway that protects against herpes simplex virus 1 infection is unique to neurons in the brain.
A study published in the journal Cell uncovers how poxviruses take control of a protein complex in order to enhance their replication and counteract an immune response in hosts.
Samantha Genardi, a fourth-year student in the Driskill Graduate Program (DGP), studies cell response to bacterial infection in the laboratory of Chyung-Ru Wang, PhD, professor of Microbiology-Immunology.
Mutations in a gene called DBR1 may increase patients’ susceptibility to brain infection, according to a study published in Cell.
A new study advances the understanding of how human cytomegalovirus replicates within cells and also reveals potential treatment targets for the common virus.